SETD2 in MLL-rearranged leukemia–a complex case

1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Oncogenic MLL-fusion proteins often hijack essential molecular mechanisms during leukemogenesis. The histone methyltransferase SETD2 was implicated in the regulation of transcription, DNA damage and other cellular processes. Recent studies identified a critical role for SETD2 in MLL-rearranged leukemia. These results may help to unravel important functions of SETD2 in hematopoiesis.

Cite

CITATION STYLE

APA

Skucha, A., Ebner, J., & Grebien, F. (2018). SETD2 in MLL-rearranged leukemia–a complex case. Molecular and Cellular Oncology, 5(4). https://doi.org/10.1080/23723556.2018.1503492

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free